User profiles for Emma C Wall
Emma WallFrancis Crick Institute; University College London Verified email at crick.ac.uk Cited by 2572 |
Neutralising antibody activity against SARS-CoV-2 VOCs B. 1.617. 2 and B. 1.351 by BNT162b2 vaccination
that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of currently
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …
[HTML][HTML] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
[HTML][HTML] AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
The SARS-CoV-2 B. 1.617. 2 Delta variant of concern (VOC) continues to drive a sharp increase
in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 consistent …
in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 consistent …
[HTML][HTML] Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Patients with cancer are at greater risk of severe COVID-19 and have been prioritised for
COVID-19 vaccination globally. We previously showed that following two doses of COVID-19 …
COVID-19 vaccination globally. We previously showed that following two doses of COVID-19 …
Three-dose vaccination elicits neutralising antibodies against omicron
Omicron, the SARS-CoV-2 B. 1.1. 529 variant of concern (VOC), was first detected in southern
Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK. Omicron …
Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK. Omicron …
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients
We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy study. …
patients and the healthy individuals we have already reported on as part of the Legacy study. …
Community-acquired bacterial meningitis
Progress has been made in the prevention and treatment of community-acquired bacterial
meningitis during the past three decades but the burden of the disease remains high globally. …
meningitis during the past three decades but the burden of the disease remains high globally. …
[PDF][PDF] Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Patients with cancer are at higher risk of severe COVID-19 (Grivas et al., 2021; Kuderer et al.,
2020), and they are currently prioritized globally for a third COVID-19 vaccine dose. …
2020), and they are currently prioritized globally for a third COVID-19 vaccine dose. …
[HTML][HTML] Acute bacterial meningitis
… Serogroup C Incidence has declined dramatically following the introduction of Men-C
vaccine in children in many high-income countries [36–38] . Epidemic meningitis caused by …
vaccine in children in many high-income countries [36–38] . Epidemic meningitis caused by …
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
The main limitation of our study is its observational nature, risking unbalanced groups for
comparisons. For example, the AZD–AZD–BNT and BNT–BNT–BNT cohorts are matched …
comparisons. For example, the AZD–AZD–BNT and BNT–BNT–BNT cohorts are matched …